Furthermore, both CSF+/PET− and CSF−/PET+ individuals had higher CSF p-Tau/Aβ40 ratios than the CSF−/PET− individuals, implying that the early abnormal tau increases in CSF36,49,50 are detectable in early amyloidosis stage. The gene discussed is MAPT; the disease is amyloidosis.